EFFICACY AND SAFETY OF VALRUBICIN FOR THE TREATMENT OF BACILLUS CALMETTE-GUERIN REFRACTORY CARCINOMA IN SITU OF THE BLADDER
Top Cited Papers
- 1 March 2000
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 163 (3) , 761-767
- https://doi.org/10.1016/s0022-5347(05)67799-3
Abstract
The Journal of Urology 163 (2000) 761-767. doi:10.1016/S0022-5347(05)67799-3Received by publisher: 0000-01-01Harvest Date: 2016-01-04 12:20:26DOI: 10.1016/S0022-5347(05)67799-3Page Range: 761-76Keywords
This publication has 14 references indexed in Scilit:
- SUPERFICIAL BLADDER CANCER: THE ROLE OF INTERFERON-alphaJournal of Urology, 1998
- Additional bacillus calmette-guérin therapy for recurrent transitional cell carcinoma after an initial complete responseUrology, 1997
- A Randomized Prospective Study Comparing Long-Term Intravesical Instillations of Mitomycin C and Bacillus Calmette-Guerin in Patients with Superficial Bladder CarcinomaJournal of Urology, 1996
- Oral bropirimine immunotherapy of carcinoma in situ of the bladder: results of a phase II trialUrology, 1996
- MANAGEMENT OF PROSTATE AND BLADDER CANCER IN THE ELDERLYUrologic Clinics of North America, 1996
- Carcinoma in Situ of the BladderJournal of Urology, 1995
- WHEN INTRAVESICAL MEASURES FAILUrologic Clinics of North America, 1992
- Long-Term Followup of Patients Treated With 1 or 2, 6-Week Courses of Intravesical Bacillus Calmette-Guerin: Analysis of Possible Predictors of Response Free of TumorJournal of Urology, 1990
- The Response of Patients with Superficial Bladder Cancer to a Second Course of Intravesical Bacillus Calmette-GuerinJournal of Urology, 1990
- Risks and Benefits of Repeated Courses of Intravesical Bacillus Calmette-guerin Therapy for Superficial Bladder CancerJournal of Urology, 1987